Coagulo Medical Technologies, founded in 2018, is making significant strides in the health care industry. The company's mission, encapsulated in its slogan "Innovating medicine with a portable and connected precision-medicine platform for smarter coagulation management, ensuring better healthcare outcomes for all," speaks volumes about its commitment to driving positive change in the field of medicine. Coagulo is transforming healthcare through its pioneering portable and connected precision-medicine platform, which is designed to revolutionize the management of coagulation. This innovation ultimately contributes to the enhancement of healthcare outcomes for all. The company recently secured a noteworthy $6.50M Venture Round investment on 22 December 2020. The investors in this round include prominent names such as 20/20 HealthCare Partners, Good Growth Capital, Sands Capital Ventures, and IAG Capital Partners. This funding is a testament to the confidence that industry leaders have in Coagulo's vision and the potential impact of its innovative approach. Coagulo's emphasis on precision medicine in coagulation management sets it apart in the health care landscape. With its recent investment success and support from leading investors, the company is poised to drive significant advancements in the field, promising a brighter future for healthcare outcomes.
No recent news or press coverage available for Coagulo Medical Technologies.